1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. UNITED STATES AI IN CLINICIAL TRIALS MARKET BY PROCESS
5.1. Introduction
5.2. Trial Design
5.3. Patient Selection
5.4. Site Selection
5.5. Patient Monitoring
6. UNITED STATES AI IN CLINICIAL TRIALS MARKET BY APPLICATION
6.1. Introduction
6.2. Biosensors
6.3. Smartphone Applications
6.4. Wearables
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Market Share Analysis
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Competitive Dashboard
8. COMPANY PROFILES
8.1. ConcertAI
8.2. Saama Technologies LLC
8.3. PathAI
8.4. Owkin Inc.
8.5. Aitia
8.6. Neuroute
8.7. AiCure
8.8. Unlearn AI
8.9. VeriSIM Life
9. APPENDIX
9.1. Currency
9.2. Assumptions
9.3. Base and Forecast Years Timeline
9.4. Key benefits for the stakeholders
9.5. Research Methodology
9.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES